StonvexLoading…
StonvexStonvexStonvexCore line items from MUR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $816.96M | $732.35M | $2.69B | $721.00M | $683.00M |
Operating Income | Not available | $138.26M | $301.24M | $241.90M | $236.10M |
Net Income | Not available | $52.99M | $104.23M | $-3.00M | $22.30M |
EPS (Diluted) | $1.17 | $0.37 | $0.72 | $-0.02 | $0.16 |
Total Assets | Not available | $10.04B | $9.83B | $9.73B | $9.84B |
Total Liabilities | Not available | $4.80B | $4.60B | $4.48B | $4.48B |
Cash & Equivalents | Not available | $378.75M | $377.20M | $425.96M | $379.63M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 143.35M | 142.79M | 142.73M | 142.73M |